BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+49.08%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$18.8B
AUM Growth
+$18.8B
Cap. Flow
-$433M
Cap. Flow %
-2.3%
Top 10 Hldgs %
85.02%
Holding
117
New
8
Increased
21
Reduced
10
Closed
18

Top Buys

1
EXAS icon
Exact Sciences
EXAS
$239M
2
KOD icon
Kodiak Sciences
KOD
$137M
3
DBVT
DBV Technologies
DBVT
$97.4M
4
AUPH icon
Aurinia Pharmaceuticals
AUPH
$34.5M
5
KRRO icon
Korro Bio
KRRO
$21.6M

Top Sells

1
GHDX
Genomic Health, Inc.
GHDX
$627M
2
AMRN
Amarin Corp
AMRN
$151M
3
NGNE icon
Neurogene
NGNE
$97.4M
4
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
$72.9M
5
BOLD
Audentes Therapeutics, Inc
BOLD
$42M

Sector Composition

1 Healthcare 98.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ONCE
101
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-751,927
Closed -$72.9M
ACHN
102
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
– –
-1,095,359
Closed -$3.94M
DERM
103
DELISTED
Dermira, Inc.
DERM
– –
-906,943
Closed -$5.8M
FOMX
104
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-498,189
Closed -$1.51M
FTSV
105
DELISTED
Forty Seven, Inc. Common Stock
FTSV
– –
-250,000
Closed -$1.61M
XLRN
106
DELISTED
Acceleron Pharma Inc.
XLRN
– –
-83,900
Closed -$3.32M
SRRA
107
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-2,000,000
Closed -$781K
ACOR
108
DELISTED
Acorda Therapeutics, Inc.
ACOR
– –
-2,232,589
Closed -$6.41M
CBAY
109
DELISTED
Cymabay Therapeutics
CBAY
– –
-5,707,411
Closed -$29.2M
XBIT icon
110
XBiotech
XBIT
$90.9M
– –
-521,327
Closed -$5.45M
QLGN icon
111
Qualigen Therapeutics
QLGN
$2.95M
– –
-279,999
Closed -$87K
MIST icon
112
Milestone Pharmaceuticals
MIST
$151M
– –
-266,667
Closed -$4.97M
HALO icon
113
Halozyme
HALO
$8.75B
– –
-299,969
Closed -$4.65M
CYCN icon
114
Cyclerion Therapeutics
CYCN
$7.75M
– –
-202,581
Closed -$2.46M
AQST icon
115
Aquestive Therapeutics
AQST
$478M
– –
-99,600
Closed -$317K
1 2 3 4
5